1. Home
  2. FBK vs NRIX Comparison

FBK vs NRIX Comparison

Compare FBK & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FB Financial Corporation

FBK

FB Financial Corporation

HOLD

Current Price

$55.00

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$26.13

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBK
NRIX
Founded
1906
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
FBK
NRIX
Price
$55.00
$26.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
12
Target Price
$64.50
$30.50
AVG Volume (30 Days)
230.8K
1.0M
Earning Date
04-13-2026
04-08-2026
Dividend Yield
1.56%
N/A
EPS Growth
N/A
N/A
EPS
2.24
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$41.72
N/A
Revenue Next Year
$7.21
$48.05
P/E Ratio
$25.44
N/A
Revenue Growth
N/A
99.31
52 Week Low
$49.74
$8.20
52 Week High
$62.66
$28.23

Technical Indicators

Market Signals
Indicator
FBK
NRIX
Relative Strength Index (RSI) 38.03 52.95
Support Level $55.29 $14.63
Resistance Level $56.77 $28.23
Average True Range (ATR) 1.07 1.02
MACD -0.30 -0.26
Stochastic Oscillator 18.70 34.45

Price Performance

Historical Comparison
FBK
NRIX

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: